The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPersimmon Regulatory News (PSN)

Share Price Information for Persimmon (PSN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,424.50
Bid: 1,428.50
Ask: 1,430.00
Change: 18.00 (1.28%)
Spread: 1.50 (0.105%)
Open: 1,419.00
High: 1,440.00
Low: 1,418.50
Prev. Close: 1,406.50
PSN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

25 Apr 2018 16:21

RNS Number : 1305M
Persimmon PLC
25 April 2018
 

 

 

25 April 2018

 

PERSIMMON PLC (THE 'COMPANY')

ANNUAL GENERAL MEETING - POLL RESULTS

 

Persimmon Plc held its Annual General Meeting for shareholders at 12 noon today. All resolutions set out in the Company's Notice of Annual General Meeting dated 19 March 2018 were duly passed by shareholders by means of a poll vote. The total number of votes received for each resolution is set out below.

 

Resolution

For

% For

Against

% Against

Total Votes

% of Issued Share Capital

Votes Withheld

1

Receive report and accounts

208,033,327

99.87

273,851

0.13

208,307,178

66.91%

541,227

2

Declare final dividend

208,425,902

99.88

248,660

0.12

208,674,562

67.03%

146,999

3

Approve Annual Report on Remuneration

74,465,763

51.48

70,188,301

48.52

144,654,064

46.47%

64,805,538

4

Re-elect N Mills

186,130,621

89.24

22,433,070

10.76

208,563,691

67.00%

284,320

5

Re-elect J Fairburn

202,857,911

97.78

4,608,170

2.22

207,466,081

66.64%

1,382,175

6

Re-elect M Killoran

201,983,363

97.36

5,480,109

2.64

207,463,472

66.64%

1,384,784

7

Re-elect D Jenkinson

200,495,390

96.64

6,962,899

3.36

207,458,289

66.64%

1,390,172

8

Re-elect M Sears

187,216,178

89.66

21,583,133

10.34

208,799,311

67.07%

49,150

9

Re-elect R Kentleton

207,037,055

99.16

1,759,657

0.84

208,796,712

67.07%

51,749

10

Re-elect S Litherland

188,999,983

90.52

19,791,165

9.48

208,791,148

67.07%

57,313

11

Re-appoint auditor

208,768,265

99.97

56,407

0.03

208,824,672

67.08%

23,789

12

Authorise Audit Committee to determine the auditor's remuneration

208,739,155

99.97

55,122

0.03

208,794,277

67.07%

54,184

13

Approve 2018 SAYE

204,793,463

98.09

3,994,956

1.91

208,788,419

67.07%

60,042

14

Renew authority to allot shares

201,805,370

96.65

7,001,677

3.35

208,807,047

67.07%

41,264

15

Renew authority to disapply pre-emption rights

208,490,254

99.85

306,942

0.15

208,797,196

67.07%

51,265

16

Authorise Company to make market purchases of shares

206,178,928

98.75

2,618,939

1.25

208,797,867

67.07%

50,224

17

Calling of a general meeting on not less than 14 days' notice

181,261,853

87.22

26,560,410

12.78

207,822,263

66.76%

1,026,198

 

 

 

 

We note that whilst the vote on the retrospective Advisory Remuneration Report was passed by shareholders at our AGM today, there were 51.5% in favour, 48.5% against and 30.9% abstained. Although the Executive Directors made significant reductions and adjustments to their 2012 LTIP awards - a scheme that was approved by 85% of shareholders in 2012 - we recognise that a sizeable number of shareholders remained concerned over the level of remuneration that ultimately resulted from the vesting of these 2012 awards.

 

As part of the regular interaction with shareholders and following the resignations of the Chairman and Remuneration Committee Chair in recognition of the absence of a cap to the 2012 LTIP scheme, the Acting Chairman and new Remuneration Chair undertook further extensive shareholder engagement in 2018, speaking with shareholders on a number of occasions.

 

In February 2018, the Executive Directors informed the Remuneration Committee of a series of decisions intended to reduce the scale of payments under the 2012 LTIP, to cap the future value on exercise to a maximum value equal to £29 per share, to extend the holding periods under any second tranche and to make these changes subject to continued employment.

 

We are grateful for the support that allows us to draw a line under the 2012 LTIP debate and move forward.

 

In this context, shareholders at last year's AGM approved the 2017 Performance Share Plan (2017 PSP) with a vote in favour of over 95% for the new Plan. At the same time we adopted a new remuneration policy which included provision to grant awards to the Executive Directors under the 2017 PSP. The vote in favour of this new remuneration policy was over 96%. There will not be any PSP awards to Executive Directors in calendar year 2018. We will consult with our major shareholders on quantum and metrics for future awards for Executive Directors under the new Plan, and awards made to this group will only be granted after the 2012 LTIP has vested (i.e. when the Capital Return Plan has returned £1.9bn to shareholders). The earliest that any PSP awards would be granted to Executive Directors is therefore 2019. The earliest vesting date for such awards would be 31 December 2021 with a holding period for two further years i.e. until December 2023.

 

For 2018, in addition to the reduction and amendments to the 2012 LTIP awards, all Directors have waived increases to their salaries. The Executive Directors have also waived participation in any bonus for 2018, and the Remuneration Committee has endorsed the Executives' request that any such bonuses be distributed to staff who have not participated in the 2012 LTIP and 2017 PSP.

 

Total shareholder returns to date from the launch of the Group's new strategy in 2012 now exceed 500%, placing us at number 2 in the FTSE 100 and we have delivered more than £8bn to shareholders in that period.

 

Finally, we have announced the appointment of a new Chairman, Roger Devlin, who will join the Board and the Remuneration Committee on 1 June 2018.

 

Notes:

 

(i)

Resolutions 1-14 were ordinary resolutions and resolutions 15-17 were special resolutions.

(ii)

Discretionary votes representing 0.1% (or less) of the votes cast were also received on each resolution and are included in the votes 'For' each resolution.

(iii)

A "vote withheld" is not a vote in law and is not counted in the total number of votes cast on a resolution or in the calculation of the percentages of the votes cast for or against a resolution.

(iv)

Copies of the resolutions dealing with special business passed at the Annual General Meeting have been sent to the National Storage Mechanism and will shortly be available for inspection.

(v)

The poll results will be available to view on the Company's website https://www.persimmonhomes.com/corporate/investors/shareholder-information/meeting-information

(vi)

The issued share capital of the Company on 23 April 2018 was 311,304,918 ordinary shares.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RAGBUGDSIBDBGIU
Date   Source Headline
1st May 20241:11 pmRNSTotal Voting Rights
30th Apr 20242:03 pmRNSDirectorate Change
25th Apr 20242:09 pmRNSResult of AGM
25th Apr 20247:00 amRNSQ1 Trading Statement
2nd Apr 20241:49 pmRNSTotal Voting Rights
28th Mar 202412:53 pmRNSDirector/PDMR Shareholding
25th Mar 20244:47 pmRNSDirector/PDMR Shareholding
25th Mar 20242:07 pmRNSAnnual Report 2023 and Notice of AGM 2024
12th Mar 20241:38 pmRNSDirector/PDMR Shareholding
12th Mar 20247:00 amRNSFull Year Results
11th Jan 20246:00 pmRNSDechra Pharmaceuticals
10th Jan 20247:00 amRNSTrading Statement
1st Dec 20234:48 pmRNSBlock listing Interim Review
1st Dec 20234:45 pmRNSTotal Voting Rights
17th Nov 202310:25 amRNSHolding(s) in Company
8th Nov 20237:00 amRNSAppointment of Chief Financial Officer
7th Nov 20237:00 amRNSQ3 Trading Statement
3rd Nov 20231:15 pmRNSHolding(s) in Company
1st Sep 20231:15 pmRNSTotal Voting Rights
10th Aug 20237:04 amRNSHalf Year Results
27th Jul 202310:13 amRNSDirectorate Change
10th Jul 20239:27 amRNSDirector Declaration
3rd Jul 20232:46 pmRNSTotal Voting Rights
1st Jun 20234:38 pmRNSTR-1: Notification of major holdings
1st Jun 20231:07 pmRNSBlock listing Interim Review
1st Jun 202311:06 amRNSTotal Voting Rights
3rd May 20235:00 pmRNSHolding(s) in Company
3rd May 20234:12 pmRNSDirector/PDMR Shareholding
2nd May 202311:13 amRNSTotal Voting Rights
26th Apr 20234:32 pmRNSResult of AGM
26th Apr 20237:00 amRNSQ1 Trading Statement
3rd Apr 20234:01 pmRNSDirector/PDMR Shareholding
3rd Apr 20233:05 pmRNSTotal Voting Rights
27th Mar 20233:44 pmRNSDirector/PDMR Shareholding
22nd Mar 20233:00 pmRNSAnnual Report 2022 and Notice of AGM 2023
13th Mar 20231:57 pmRNSDirectorate Change
13th Mar 202312:19 pmRNSUK Government Self Remediation Contract Signed
7th Mar 20235:33 pmRNSHolding(s) in Company
7th Mar 20237:04 amRNSDirector Declaration
6th Mar 20235:02 pmRNSHolding(s) in Company
1st Mar 20237:00 amRNSFull Year Results
12th Jan 20237:00 amRNSTrading Statement
1st Dec 20225:30 pmRNSBLOCK LISTING SIX MONTHLY RETURN
1st Dec 20225:25 pmRNSVoting Rights and Capital
8th Nov 20227:00 amRNSTrading Statement
1st Nov 20221:00 pmRNSTotal Voting Rights
1st Nov 20229:24 amRNSHolding(s) in Company
10th Oct 20222:24 pmRNSDirector/PDMR Shareholding
5th Oct 202210:26 amRNSHolding(s) in Company
4th Oct 20223:07 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.